Literature DB >> 10544244

TRAF1 is a TNF inducible regulator of NF-kappaB activation.

I Carpentier1, R Beyaert.   

Abstract

Tumor necrosis factor receptor (TNFR)-associated factor TRAF1 was first identified as a component of the TNFR2 signalling complex. Unlike the other members of the TRAF family, TRAF1 lacks the N-terminal ring finger motif and has a tissue specific expression. Here we demonstrate that expression of TRAF1 is induced by TNF and the protein kinase C (PKC) activator PMA, but not by interleukin-1 (IL-1). TNF-induced upregulation of TRAF1 could be prevented by pretreatment of the cells with the proteasome inhibitor MG-132, whereas the PKC inhibitor Ro31-8220 was without effect. Interestingly, overexpression of TRAF1 in HEK293T completely prevented NF-kappaB activation induced by TNF, IL-1, or overexpression of TRAF2 or TRAF6. These data suggest that inducible expression of TRAF1 may serve a negative regulatory function in NF-kappaB signalling pathways.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10544244     DOI: 10.1016/s0014-5793(99)01356-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  29 in total

1.  Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells.

Authors:  Ann J McPherson; Laura M Snell; Tak W Mak; Tania H Watts
Journal:  J Biol Chem       Date:  2012-05-08       Impact factor: 5.157

2.  The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease.

Authors:  Ali A Abdul-Sater; Maria I Edilova; Derek L Clouthier; Achire Mbanwi; Elisabeth Kremmer; Tania H Watts
Journal:  Nat Immunol       Date:  2016-11-28       Impact factor: 25.606

3.  NF-κB and Rheumatoid Arthritis: Will Understanding Genetic Risk Lead to a Therapeutic Reward?

Authors:  Robert Scheinman
Journal:  For Immunopathol Dis Therap       Date:  2013-04-01

4.  Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.

Authors:  Chao Zheng; Venkataraman Kabaleeswaran; Yaya Wang; Genhong Cheng; Hao Wu
Journal:  Mol Cell       Date:  2010-04-09       Impact factor: 17.970

5.  Acute tumor necrosis factor-alpha-induced liver injury in the absence of tumor necrosis factor receptor-associated factor 1 gene expression.

Authors:  Gloria S Pryhuber; Heidie L Huyck; Jason M Roper; Judith Cornejo; Michael A O'Reilly; Robert H Pierce; Erdyni N Tsitsikov
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

6.  Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall.

Authors:  Anna Missiou; Natascha Köstlin; Nerea Varo; Philipp Rudolf; Peter Aichele; Sandra Ernst; Christian Münkel; Carina Walter; Peter Stachon; Benjamin Sommer; Dietmar Pfeifer; Katja Zirlik; Lindsey MacFarlane; Dennis Wolf; Erdyni Tsitsikov; Christoph Bode; Peter Libby; Andreas Zirlik
Journal:  Circulation       Date:  2010-04-26       Impact factor: 29.690

Review 7.  Genetics of rheumatic disease.

Authors:  Alex Clarke; Timothy J Vyse
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

8.  Interaction of the TNFR-receptor associated factor TRAF1 with I-kappa B kinase-2 and TRAF2 indicates a regulatory function for NF-kappa B signaling.

Authors:  Kalsoom Sughra; Andreas Birbach; Rainer de Martin; Johannes A Schmid
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

9.  Translation of TRAF1 is regulated by IRES-dependent mechanism and stimulated by vincristine.

Authors:  Lin Yang; Lubing Gu; Zhuoya Li; Muxiang Zhou
Journal:  Nucleic Acids Res       Date:  2010-04-22       Impact factor: 16.971

10.  Adiponectin inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10.

Authors:  Eduardo J Folco; Viviane Z Rocha; Marco López-Ilasaca; Peter Libby
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.